Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Host Response to Lactobacillus johnsonii N6.2
NCT02349360Phase 2Completed
- Sponsor
- University of Florida
- Start
- Aug 2015
- Primary completion
- Dec 2016
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
A Phase 2 trial of lactobacillus johnsonii n6.2 in type 1 diabetes mellitus (T1D), sponsored by University of Florida. Started Aug 2015; status: completed.
02
Drugs
lactobacillus johnsonii n6.2
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02349360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02349360.